NCT00189267View on ClinicalTrials.gov

A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 30, 2002

Study Completion Date

September 30, 2005

Conditions
Actinic Keratosis
Interventions
DRUG

Imiquimod 5 % Cream

All Listed Sponsors
lead

MEDA Pharma GmbH & Co. KG

INDUSTRY

NCT00189267 - A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients | Biotech Hunter | Biotech Hunter